# Optimal Location of Nerve Block to Minimize Perioperative Opioid Administration in ACL Surgery: Comparing True Adductor Canal to Proximal Block

> **NCT03401450** · PHASE4 · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 69 (actual)

## Conditions studied

- ACL Surgery

## Interventions

- **DRUG:** ACB within true AC with bupivacaine 0.5% 20cc
- **DRUG:** ACB proximal to true AC with bupivacaine 0.5% 20cc

## Key facts

- **NCT ID:** NCT03401450
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-01
- **Primary completion:** 2019-01-25
- **Final completion:** 2021-06-29
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2023-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03401450

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03401450, "Optimal Location of Nerve Block to Minimize Perioperative Opioid Administration in ACL Surgery: Comparing True Adductor Canal to Proximal Block". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03401450. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*